Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls

ABSTRACT Multi-parametric MRI (mpMRI) is widely used in the detection and characterization of clinically- significant prostate cancer. MRI-TRUS (trans-rectal ultrasound) fusion biopsy is an in-office procedure that promises to empower urologists to successfully target these MRI-visible lesions for histological confirmation. We describe the moving parts in the process and discuss methods to optimize biopsy outcomes. mpMRI is highly technical and reader-dependent. The acquisition of US images to generate a valid 3D US model and subsequent registration and fusion requires the urologist to attain equilibrium of probe position and pressure to achieve maximum registration accuracy. Environmental, medical and engineering measures can be undertaken to improve targeting accuracy. The art and skill of ‘hitting’ a visual target involves real-time recognition and adjustment for potential errors/ mis-registration in the fusion guide. A multi-disciplinary team effort is critical to improve all steps of the procedure.

[1]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[2]  Guy Nir,et al.  Model-based registration of ex vivo and in vivo MRI of the prostate using elastography , 2013, IEEE Transactions on Medical Imaging.

[3]  T. Polascik,et al.  The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy. , 2012, Urology.

[4]  Rajan T. Gupta,et al.  Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. , 2014, Urologic oncology.

[5]  Heinz-Peter Schlemmer,et al.  Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. , 2013, The Journal of urology.

[6]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[7]  D. Sung,et al.  The optimal timing of post-prostate biopsy magnetic resonance imaging to guide nerve-sparing surgery , 2014, Asian journal of andrology.

[8]  P. Carroll,et al.  Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.

[9]  Peter L Choyke,et al.  Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.

[10]  F. Beuvon,et al.  Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? , 2015, The Journal of urology.

[11]  J. Witjes,et al.  Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. , 2015, European urology.

[12]  P. Choyke,et al.  Comparison of magnetic resonance imaging and ultrasound (MRI‐US) fusion‐guided prostate biopsies obtained from axial and sagittal approaches , 2015, BJU international.

[13]  J. Bernhard,et al.  Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer. , 2014, Urologic oncology.

[14]  M. Knopp,et al.  Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer. , 2015, Academic radiology.

[15]  P. Choyke,et al.  Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. , 2013, The Journal of urology.

[16]  S. Mendrinos,et al.  Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. , 2012, The Journal of urology.

[17]  J. Bernhard,et al.  Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. , 2015, European urology.

[18]  D. Atkinson,et al.  Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate , 2015, Prostate Cancer and Prostatic Disease.

[19]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[20]  D. Moses,et al.  Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. , 2014, The Journal of urology.

[21]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[22]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[23]  Jan van der Meulen,et al.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.

[24]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[25]  Kevin J Chang,et al.  3.0-T MR imaging of the abdomen: comparison with 1.5 T. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[26]  Kingshuk Roy Choudhury,et al.  Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis , 2014, Abdominal Imaging.

[27]  Tristan Barrett,et al.  Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool , 2016, BJU international.

[28]  R E Lenkinski,et al.  Prostate: MR imaging with an endorectal surface coil. , 1989, Radiology.

[29]  L. Kavoussi,et al.  In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12‐core biopsy still necessary in addition to a targeted biopsy? , 2015, BJU international.

[30]  David Y. Lu,et al.  Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. , 2014, The Journal of urology.

[31]  T. Polascik,et al.  Targeted prostate biopsies: the complexity behind a simple concept. , 2014, European urology.

[32]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[33]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[34]  P. Mozer,et al.  TRUS–MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer , 2013, Abdominal Imaging.

[35]  Aaron Fenster,et al.  Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. , 2014, Medical physics.

[36]  Baris Turkbey,et al.  Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.

[37]  Baris Turkbey,et al.  Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. , 2012, The Journal of urology.

[38]  H. Hricak,et al.  Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. , 2012, Radiology.

[39]  Rajan T. Gupta,et al.  The state of prostate MRI in 2013. , 2013, Oncology.

[40]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.